Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100107772 | 10010777 | 2 | F | 20140318 | 20140311 | 20140331 | EXP | AUR-APL-2014-02447 | AUROBINDO | 0.00 | UNK | N | 0.00000 | 20140328 | N | OT | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100107772 | 10010777 | 1 | PS | METFORMIN | 1 | U | 77095 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100107772 | 10010777 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100107772 | 10010777 | HO |
| 100107772 | 10010777 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100107772 | 10010777 | Blood potassium increased | |
| 100107772 | 10010777 | Blood sodium decreased | |
| 100107772 | 10010777 | Continuous haemodiafiltration | |
| 100107772 | 10010777 | Lactic acidosis | |
| 100107772 | 10010777 | Metabolic acidosis | |
| 100107772 | 10010777 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 100107772 | 10010777 | LIT |
| 100107772 | 10010777 | HP |
| 100107772 | 10010777 | FGN |
Therapies reported
| no results found |